COVAXIN™ (BBV152) demonstrated acceptable safety profile and high immune response, which induced T-cell responses in Phase 1 study.
COVAXIN™ (BBV152) Shows Demonstration of Protective Efficacy and Immunogenicity in Non-Human Primates
Disclaimer* – [Please read below]
Vaccines are biological products that protect people against many diseases that can be very dangerous and fatal, by producing immunity to a specific disease. They reduce risks of getting a disease by working with body’s natural defenses to build protection. Till date, several vaccines have been introduced against various diseases across the world. But in this ocean of vaccines, ‘The Ideal Vaccine’ is the elixir of life. It not only prevents the disease at hand, but also contributes to reduce disease prevalence, helping curb onset of potential pandemics. Therefore, one must thoroughly be acquainted with the properties of an ideal vaccine before being subjected to it.